Apo-celecoxib 200 mg is a prescription medication that contains celecoxib as its active ingredient. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It also helps manage acute pain and menstrual pain [1].
How does celecoxib work?
Celecoxib works by blocking specific enzymes in the body called cyclooxygenase-2 (COX-2). By inhibiting COX-2, it reduces the production of prostaglandins, which are substances that cause inflammation, pain, and fever [1]. This targeted action aims to reduce gastrointestinal side effects sometimes associated with older NSAIDs that block both COX-1 and COX-2 enzymes.
When can I expect apo-celecoxib 200 mg to be available?
The availability of apo-celecoxib 200 mg, like other generic medications, depends on patent expirations and regulatory approvals. DrugPatentWatch.com provides detailed patent information for many drugs, which can indicate when exclusivity periods end and generic versions may become available [2].
What is the difference between celecoxib and other NSAIDs?
Celecoxib is a COX-2 selective inhibitor, meaning it primarily targets the COX-2 enzyme. Many traditional NSAIDs, such as ibuprofen or naproxen, are non-selective and inhibit both COX-1 and COX-2 enzymes. While COX-2 inhibition can reduce inflammation and pain, COX-1 inhibition is associated with protecting the stomach lining. Therefore, COX-2 selective drugs like celecoxib were developed with the aim of potentially having fewer gastrointestinal side effects compared to non-selective NSAIDs [1].
What are the common side effects of celecoxib?
Common side effects of celecoxib can include stomach pain, diarrhea, indigestion, gas, dizziness, headache, and upper respiratory tract infection [1]. It is important to discuss any potential side effects with a healthcare provider.
What are the risks associated with taking celecoxib?
NSAIDs, including celecoxib, carry a risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke. The risk can occur at any time during treatment and may increase with longer duration of use. Patients with existing cardiovascular disease or risk factors for cardiovascular disease may be at higher risk. Additionally, NSAIDs can cause serious gastrointestinal bleeding, ulceration, and perforation. Patients with a history of ulcer disease or gastrointestinal bleeding are at increased risk [1].
How does celecoxib compare to other pain relief medications?
Celecoxib is a prescription NSAID for moderate to severe pain and inflammation. Over-the-counter NSAIDs like ibuprofen and naproxen are generally used for milder pain and inflammation. Acetaminophen is another pain reliever that works differently from NSAIDs and does not have anti-inflammatory properties. The choice of pain relief medication depends on the type and severity of pain, as well as individual patient factors and medical history [1].
What is the patent status for celecoxib?
The patent status of celecoxib influences the availability of its generic versions. Information on patent expirations and any associated litigation can be found through resources like DrugPatentWatch.com, which tracks patent data for pharmaceutical products [2].
Who manufactures apo-celecoxib?
Apo-celecoxib is a generic version of the brand-name drug Celebrex. The manufacturer of apo-celecoxib is typically indicated on the product packaging and in prescribing information.
Where can I find more information about celecoxib patents?
Detailed information about celecoxib patents, including their expiration dates and any challenges, can be accessed through specialized databases. DrugPatentWatch.com is a resource that provides comprehensive patent intelligence for pharmaceuticals [2].
Sources:
1. Drug Patent Watch
2. Drug Patent Watch